Table 1.
Patient demographics
| Variable | ND patient demographics (N = 96) |
|---|---|
| Median age, y (IQR) | 69.5 (61–79) |
| Male, n (%) | 60/96 (62.5) |
| White, n (%) | 30/96 (31.3) |
| African American, n (%) | 63/96 (65.6) |
| Admission NIHSS, median (IQR) | 10 (4–17) |
| Discharge NIHSS, median (IQR) | 9 (4–19) |
| Length of stay, median (IQR) | 8.5 (5–16) |
| mRS score at discharge, median (IQR) | 4 (3–5) |
| Favorable discharge disposition, n (%) | 58/85 (68.2) |
| Mortality, n (%) | 19/96 (20) |
| tPA given, n (%) | 31/96 (32.3) |
| TOAST, n (%) | |
| Cardioembolic | 21/77 (27.3) |
| Large vessel occlusion | 22/77 (28.6) |
| Small vessel occlusion | 16/77 (20.8) |
| Cryptogenic, >1 cause | 10/77 (13.0) |
| Cryptogenic, unknown cause | 2/77 (2.6) |
| Other | 6/77 (7.8) |
Abbreviations: IQR, interquartile range; mRS, modified Rankin Scale; ND, neurologic deterioration; NIHSS, National Institutes of Health Stroke Scale; TOAST, Trial of Org 10172 in Acute Stroke Treatment; tPA, tissue plasminogen activator.